Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study

Immunological cure of HBV infection

(2019) Julia Lang et al.   Hepatology International

Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial

(2019) Ying Zhou et al.   Hepatology International

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

(2019) Shiv Kumar Sarin et al.   Hepatology International

Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment

(2018) Margo J.H. van Campenhout et al.   HEPATOLOGY

HBV serum DNA and RNA levels in nucleos(t)ide analogue-treated or untreated patients during chronic and acute infection

(2018) Emily K. Butler et al.   HEPATOLOGY

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

(2018) Norah A. Terrault et al.   HEPATOLOGY

Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B

(2018) Florian van Bömmel et al.   JOURNAL OF INFECTIOUS DISEASES

Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection

(2018) Shi Liu et al.   HEPATOLOGY

Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread

(2017) P. Karayiannis   Hepatology International

Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?

(2017) Yuhua Gao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The role of quantitative hepatitis B surface antigen revisited

(2017) Markus Cornberg et al.   JOURNAL OF HEPATOLOGY

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Approved Antiviral Drugs over the Past 50 Years

(2016) Erik De Clercq et al.   CLINICAL MICROBIOLOGY REVIEWS

HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy

(2016) Geoffrey Dusheiko et al.   Hepatology International

Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound

(2016) Jie Wang et al.   JOURNAL OF HEPATOLOGY

Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay

(2015) Xiangbo Huang et al.   BMC INFECTIOUS DISEASES

Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues

(2015) L. Jansen et al.   JOURNAL OF INFECTIOUS DISEASES

On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy

(2014) Yi-Wen Huang et al.   ANTIVIRAL THERAPY

Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors

(2014) Florian van Bömmel et al.   HEPATOLOGY

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

(2013) Masataka Tsuge et al.   JOURNAL OF GASTROENTEROLOGY

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

(2012) Jan Budczies et al.   PLoS One